Chapter 7 Notes Flashcards
(26 cards)
zwitterionic nature of carbapenem
facilitates penetration through prin channels and increases activity against P. aeruginosa
carbapenems are highly resistant to these BLases
NSBL, BSBL, ESBL, and AmpC
carbapenems are strong inducers of
chromosomal BLase
carbapenems are hydrolyzed by these c’ases producers
S. maltophilia, some enterobact, some P. aeruginosa
there is modified resistance seen in these bugs to fight off carbapenems
G + bugs, MRSA, E. faecium, listeria, pseudomonas, acinetobacter
G + activity of carbapenems
dorip and imip > mero and erta
Dori is most effective against PRSP
G - cocci/coccobacilli activity of carbapenems
meropen and doripen > imipen
enterobact activity of carbapenem
mero and dorip > erta > imip
pseudomonas activity of carbapenems
susceptible to imipenem, merpenem, and dorpenem
Not susceptible to ertapenem
Meropenem, imipenem, and doripenem have similar
Tmax, Cmax, AUC, and half life (1 hour), very low PPB
carbapenems are removed by
dialysis so give supplemental doses
increase dose interval in severe
renal impairment
inactivation by hydrolysis
imipenem > meropenem and ertapenem
3rd gen ceph and carbapenems have low
cross reactivity
ADR
HSR I - IV (anaphylaxis, urticaria and angioedema, hematologic, serum sickness, intersitial nephritis)
stevens johnson syndrom
drug fever
Non BL producers
Streptococci Enterococci Gram positive anaerobes Bacillus, listeria, corynebacteria Spirochetes (Treponema, borrelia) Pasteurella Eikenella N. meningitides Legionella Proteus mirabilis *
NSBL producer
staph aureus
possible BSBL producers
Shigella
Salmonella
H. influenzae
N. gonorrhoeae
Use: AP+BLI, ESP+BLI, S/T/FrGC, Carbapenems
likely BSBL producers
Many other Enterobacteriaceae (CEKMPrvS) B. fragilis M. catarrhalis Acinetobacter Pseudomonads Use: Non-Pseudomonads/Enterbacteriaceae: AP+BLI, ESP+BLI, S/T/FrGC, Carbapenems* Pseudomonads/Enterbacteriaceae: ESP+BLI, T/FrGC (APCs), Carbapenems*
AmpC producers
• Nosocomial versus Community
• Chromosomal (most):
o “variable” expression: Repressed, Derepressed, Inducible*
• Inhibitors: Tazobactam (not clav or sulb)
• Substrates: Pens (except pip/tazo*), cephs (variable T/FrGCs), aztr
• Potentially Effective BLs: Pip/tazo, Carbapenems (not Erta)
Bugs:
P. aeruginosa
Enterobacteriaceae (CEMSProv)
ESBL producers
• Nosocomial versus Community • Plasmid (most): transfer by conjugation • Substrates: Pens, most cephs, Aztr • Non-substrates: Cephamycins (?) and Carbapenems • Inhibitors: Clav (variable) Bugs: E. coli K. pneumonia Other Enterobacteriaceae (few)
clavulanate (oral) inhibits these BLases
NSBL, BSBL, ESBL
does not inhibit AmpC, iRT, c’ases
sulbactam (IV) inhibits these BLases
NSBL, BSBL
does not inhibit ESBL, AmpC, iRT, c’ases
tazobactam (IV) inhibits these BLases
NSBL, BSBL, AmpC
does not inhibit ESBL, iRT, c’ases